Epilepsy and Vitamin D

References

• Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357:266–81.
   PubMed Web of Science ®Google Scholar
• Grant WB. An estimate of the global reduction in mortality rates through doubling vitamin D levels. Eur J Clin Nutr 2011;65:1016–26.
   PubMedGoogle Scholar
• Balion C, Griffith LE, Strifler L, Vitamin D, cognition, and dementia: a systematic review and meta-analysis. Neurology 2012;79:1397–405.
   PubMed Web of Science ®Google Scholar
• Eyles DW, Burne TH, McGrath JJ. Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Front Neuroendocrinol 2013;34:47–64.
   PubMed Web of Science ®Google Scholar
• Mowry EM, Waubant E, McCulloch CE, Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis. Ann Neurol 2012;72:234–40.
   PubMed Web of Science ®Google Scholar
• Pogge E. Vitamin D and Alzheimer's disease: is there a link? Consult Pharm 2010;25:440–50.
   PubMedGoogle Scholar
• Annweiler C, Llewellyn DJ, Beauchet O. Low serum vitamin D concentrations in Alzheimer's disease: a systematic review and meta-analysis. J Alzheimers Dis 2013;33:659–74.
   PubMed Web of Science ®Google Scholar
• Knekt P, Kilkkinen A, Rissanen H, Serum vitamin D and the risk of Parkinson disease. Arch Neurol 2010;67:808–811.
   PubMedGoogle Scholar
• Cannell JJ, Grant WB. What is the role of vitamin D in autism? Dermatoendocrinol 2013;5:199–204.
   PubMedGoogle Scholar
• Grant WB, Cannell JJ. Autism prevalence in the United States with respect to solar ultraviolet-B doses: an ecological study. Dermatoendocrinol 2013;5:159–64.
   PubMedGoogle Scholar
• Cannell JJ. Autism and vitamin D. Med Hypotheses 2008;70:750–9.
   PubMed Web of Science ®Google Scholar
• McGrath JJ, Burne TH, Féron F, Developmental vitamin D deficiency and risk of schizophrenia: a 10-year update. Schizophr Bull 2010;36:1073–8.
   PubMed Web of Science ®Google Scholar
• Chowdhury R, Stevens S, Ward H, Circulating vitamin D, calcium and risk of cerebrovascular disease: a systematic review and meta-analysis. Eur J Epidemiol 2012;27: 581–91.
   PubMed Web of Science ®Google Scholar
• Eyles DW, Smith S, Kinobe R, Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 2005;29:21–30.
   PubMed Web of Science ®Google Scholar
• Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J of Physiol Renal Physiol 2005;289:F8–28.
   PubMed Web of Science ®Google Scholar
• McGrath J, Feron F, Eyles D, Mackay-Sim A. Vitamin D: the neglected neurosteroid? Trends Neurosci 2001;24: 570–2.
   PubMed Web of Science ®Google Scholar
• Eyles D, Burne T, McGrath J. Vitamin D: A neurosteroid affecting brain development and function; implications for neurological and psychiatric disorders. In: Feldman D, Pike JW, Adams JS, eds. Vitamin D. 3rd ed. Amsterdam, The Netherlands: Academic Press; 2011.
   Google Scholar
• Reddy DS. Role of neurosteroids in catamenial epilepsy. Epilepsy Res 2004;62:99–118.
   PubMed Web of Science ®Google Scholar
• Procopio M, Marriott PK, Williams P. Season of birth: aetiological implications for epilepsy. Seizure 1997;6:99–105.
   PubMedGoogle Scholar
• Procopio M, Marriott PK. Seasonality of birth in epilepsy: a Danish study. Acta Neurol Scand 1998;98:297–301.
   PubMedGoogle Scholar
• Procopio M, Marriott PK, Davies RJ. Seasonality of birth in epilepsy: a Southern Hemisphere study. Seizure 2006;15:17–21.
   PubMedGoogle Scholar
• Baxendale S. Seeing the light? Seizures and sunlight. Epilepsy Res 2009;84:72–6.
   PubMedGoogle Scholar
• Clemens Z, Holló A, Kelemen A, Seasonality in epileptic seizures. J Neurol Transl Neurosci 2013;1:1016.
   Google Scholar
• Cortez MA, Burnham WM, Hwang PA. Infantile spasms: seasonal onset differences and zeitgebers. Pediatr Neurol 1997;16:220–4.
   PubMedGoogle Scholar
• Perret EV, von Elm E, Lienert C, Steinlin M. Infantile spasms: does season influence onset and long-term outcome? Pediatr Neurol 2010;43:92–96.
   PubMedGoogle Scholar
• Danesi MA. Seasonal variations in the incidence of photoparoxysmal response to stimulation among photosensitive epileptic patients: evidence from repeated EEG recordings. J Neurol Neurosurg Psychiatry 1988;51:875–57.
   PubMed Web of Science ®Google Scholar
• Danesi MA. Danesi replies. J Neurol Neurosurg Psychiatry 1989;52:548.
   Google Scholar
• Danesi MA. Electroencephalographic manifestations of grand mal epilepsy in Africans: observation of relative rarity of interictal abnormalities. Epilepsia 1988;29:446–50.
   PubMedGoogle Scholar
• Christiansen C, Rodbro P, Sjö O. “Anticonvulsant action” of vitamin D in epileptic patients? A controlled pilot study. Br Med J 1974;2:258–9.
   PubMedGoogle Scholar
• Holló A, Clemens Z, Kamondi A, Correction of vitamin D deficiency improves seizure control in epilepsy: a pilot study. Epilepsy Behav 2012;24:131–3.
   PubMed Web of Science ®Google Scholar
• Siegel A, Malkowitz L, Moskovits MJ, Christakos S. Administration of 1,25-dihydroxyvitamin D3 results in the elevation of hippocampal seizure threshold levels in rats. Brain Res 1984;298:125–9.
   Google Scholar
• Kalueff AV, Minasyan A, Tuohimaa P. Anticonvulsant effects of 1,25-dihydroxyvitamin D in chemically induced seizures in mice. Brain Res Bull 2005;67:156–60.
   PubMed Web of Science ®Google Scholar
• Kalueff AV, Minasyan A, Keisala T. Increased severity of chemically induced seizures in mice with partially deleted Vitamin D receptor gene. Neurosci Lett 2006;394:69–73.
   PubMed Web of Science ®Google Scholar
• Borowicz KK, Morawska M, Furmanek-Karwowska K, Cholecalciferol enhances the anticonvulsant effect of conventional antiepileptic drugs in the mouse model of maximal electroshock. Eur J Pharmacol 2007;573:111–5.
   PubMed Web of Science ®Google Scholar
• Ramagopalan SV, Heger A, Berlanga AJ, A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res 2010;20:1352–60.
   PubMed Web of Science ®Google Scholar
• de Viragh PA, Haglid KG, Celio MR. Parvalbumin increases in the caudate putamen of rats with vitamin D hypervitaminosis. Proc Natl Acad Sci USA 1989;86:3887–90.
   PubMedGoogle Scholar
• Wion D, MacGrogan D, Neveu I, 1,25-Dihydro- xyvitamin D3 is a potent inducer of nerve growth factor synthesis. J Neurosci Res 1991;28:110–4.
   PubMed Web of Science ®Google Scholar
• Neveu I, Naveilhan P, Baudet C, 1,25-dihydroxyvitamin D3 regulates NT-3, NT-4 but not BDNF mRNA in astrocytes. Neuroreport 1994;6:124–6.
   PubMed Web of Science ®Google Scholar
• Naveilhan P, Neveu I, Wion D, Brachet P. 1,25-Dihydroxyvitamin D3, an inducer of glial cell line-derived neurotrophic factor. Neuroreport 1996;7:2171–5.
   PubMed Web of Science ®Google Scholar
• Garcion E, Nataf S, Berod A, 1,25-Dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis. Brain Res Mol Brain Res 1997;45:255–67.
   PubMedGoogle Scholar
• Schwaller B, Tetko IV, Tandon P, Parvalbumin deficiency affects network properties resulting in increased susceptibility to epileptic seizures. Mol Cell Neurosci 2004;25:650–63.
   PubMed Web of Science ®Google Scholar
• Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J 2011; 357:593–615.
   Google Scholar
• Garcion E, Wion-Barbot N, Montero-Menei CN, New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 2002;13:100–5.
   PubMed Web of Science ®Google Scholar
• Mizwicki MT, Norman AW. Vitamin D sterol/VDR conformational dynamics and nongenomic actions. In: Feldman D, Pike JW, Adams JS, eds. Vitamin D. 3rd ed. Amsterdam, The Netherlands: Academic Press; 2011.
   Google Scholar
• Kalueff AV, Minasyan A, Keisala T, The vitamin D neuroendocrine system as a target for novel neurotropic drugs. CNS Neurol Disord Drug Targets 2006;5:363–71.
   PubMedGoogle Scholar
• Hosie AM, Wilkins ME, da Silva HM, Smart TG. Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites. Nature 2006;444:486–69.
   PubMed Web of Science ®Google Scholar
• Reddy DS, Rogawski MA. Neurosteroids—endogenous regulators of seizure susceptibility and role in the treatment of epilepsy. In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV, eds. Jasper's Basic Mechanisms of the Epilepsies. 4th edition. Bethesda, MD: National Center for Biotechnology Information (US); 2012.
   Google Scholar
• Verrotti A, Coppola G, Parisi P, Bone and calcium metabolism and antiepileptic drugs. Clin Neurol Neurosurg 2010;112:1–10.
   PubMed Web of Science ®Google Scholar
• Kruse R. Osteopathies in antiepileptic long-term therapy. Monatsschr Kinderheilkd 1968;116:378–81.
   PubMedGoogle Scholar
• Dent CE, Richens A, Rowe DJ, Stamp TC. Osteomalacia with long-term anticonvulsant therapy in epilepsy. Br Med J 1970;4:69–72.
   PubMed Web of Science ®Google Scholar
• Beauchet O, Annweiler C, Verghese J, Biology of gait control: vitamin D involvement. Neurology 2011;76:1617–22.
   PubMedGoogle Scholar
• Murad MH, Elamin KB, Abu Elnour NO, Clinical review: The effect of vitamin D on falls: a systematic review and meta-analysis. J Clin Endocrinol Metab 2011;96:2997–3006.
   PubMed Web of Science ®Google Scholar
• Mintzer S, Boppana P, Toguri J, DeSantis A. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine. Epilepsia 2006;47:510–15.
   PubMed Web of Science ®Google Scholar
• Pack AM, Morrell MJ, Marcus R, Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy. Ann Neurol 2005;57:252–7.
   PubMed Web of Science ®Google Scholar
• Pack AM, Morrell MJ, McMahon DJ, Shane E. Normal vitamin D and low free estradiol levels in women on enzyme-inducing antiepileptic drugs. Epilepsy Behav 2011;21:453–8.
   PubMed Web of Science ®Google Scholar
• Zerwekh JE, Homan R, Tindall R, Pak CY. Decreased serum 24,25-dihydroxyvitamin D concentration during long-term anticonvulsant therapy in adult epileptics. Ann Neurol 1982;12:184–6.
   PubMed Web of Science ®Google Scholar
• Tjellesen L, Christiansen C. Serum vitamin D metabolites in epileptic patients treated with 2 different anti-convulsants. Acta Neurol Scand 1982;66:335–41.
   PubMed Web of Science ®Google Scholar
• Hoikka V, Alhava EM, Karjalainen P, Carbamazepine and bone mineral metabolism. Acta Neurol Scand 1984;70:77–80.
   PubMed Web of Science ®Google Scholar
• Gough H, Goggin T, Bissessar A, A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out-patients with epilepsy. Q J Med 1986;59:569–77.
   PubMedGoogle Scholar
• Välimäki MJ, Tiihonen M, Laitinen K, Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs. J Bone Miner Res 1994;9:631–7.
   PubMed Web of Science ®Google Scholar
• Lau KH, Nakade O, Barr B, Phenytoin increases markers of osteogenesis for the human species in vitro and in vivo. J Clin Endocrinol Metab 1995;80:2347–53.
   PubMed Web of Science ®Google Scholar
• Feldkamp J, Becker A, Witte OW, Long-term anticonvulsant therapy leads to low bone mineral density–evidence for direct drug effects of phenytoin and carbamazepine on human osteoblast-like cells. Exp Clin Endocrinol Diabetes 2000;108:37–43.
   PubMed Web of Science ®Google Scholar
• Filardi S, Guerreiro CA, Magna LA, Marques Neto JF. Bone mineral density, vitamin D and anticonvulsant therapy. Arq Neuropsiquiatr 2000;58:616–20.
   PubMed Web of Science ®Google Scholar
• Kulak CA, Borba VZ, Bilezikian JP, Bone mineral density and serum levels of 25 OH vitamin D in chronic users of antiepileptic drugs. Arq Neuropsiquiatr 2004;62:940–8.
   PubMed Web of Science ®Google Scholar
• Kumandas S, Koklu E, Gümüs H, Effect of carbamezapine and valproic acid on bone mineral density, IGF-I and IGFBP-3. J Pediatr Endocrinol Metab 2006;19:529–34.
   PubMed Web of Science ®Google Scholar
• El-Hajj Fuleihan G, Dib L, Yamout B, Predictors of bone density in ambulatory patients on antiepileptic drugs. Bone 2008;43:149–55.
   PubMed Web of Science ®Google Scholar
• Verrotti A, Greco R, Morgese G, Chiarelli F. Increased bone turnover in epileptic patients treated with carbamazepine. Ann Neurol 2000;47:385–8.
   PubMed Web of Science ®Google Scholar
• Verrotti A, Greco R, Latini G, Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine. Epilepsia 2002;43:1488–92.
   PubMed Web of Science ®Google Scholar
• Nicolaidou P, Georgouli H, Kotsalis H, Effects of anticonvulsant therapy on vitamin D status in children: prospective monitoring study. J Child Neurol 2006;21:205–9.
   PubMed Web of Science ®Google Scholar
• Kim SH, Lee JW, Choi KG, A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy. Epilepsy Behav 2007;10:291–5.
   PubMed Web of Science ®Google Scholar
• Misra A, Aggarwal A, Singh O, Sharma S. Effect of carbamazepine therapy on vitamin D and parathormone in epileptic children. Pediatr Neurol 2010;43:320–4.
   PubMed Web of Science ®Google Scholar
• Menon B, Harinarayan CV. The effect of anti epileptic drug therapy on serum 25-hydroxyvitamin D and parameters of calcium and bone metabolism-a longitudinal study. Seizure 2010;19:153–8.
   PubMed Web of Science ®Google Scholar
• Brämswig S, Zittermann A, Berthold HK. Carbamazepine does not alter biochemical parameters of bone turnover in healthy male adults. Calcif Tissue Int 2003;73:356–60.
   PubMedGoogle Scholar
• Bell RD, Pak CY, Zerwekh J, Effect of phenytoin on bone and vitamin D metabolism. Ann Neurol 1979;5:374–8.
   PubMed Web of Science ®Google Scholar
• Krishnamoorthy G, Nair R, Sundar U, Early predisposition to osteomalacia in Indian adults on phenytoin or valproate monotherapy and effective prophylaxis by simultaneous supplementation with calcium and 25-hydroxy vitamin D at recommended daily allowance dosage: a prospective study. Neurol India 2010;58:213–9.
   PubMed Web of Science ®Google Scholar
• Pascussi JM, Robert A, Nguyen M, Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia. J Clin Invest 2005;115:177–86.
   PubMed Web of Science ®Google Scholar
• Zhou C, Assem M, Tay JC, Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. J Clin Invest 2006;116:1703–12.
   PubMed Web of Science ®Google Scholar
• Hahn TJ, Birge SJ, Scharp CR, Avioli LV. Phenobarbital-induced alterations in vitamin D metabolism. J Clin Invest 1972;51:741–8.
   PubMed Web of Science ®Google Scholar
• Christiansen C, Rodbro P, Lund M. Incidence of anticonvulsant osteomalacia and effect of vitamin D: controlled therapeutic trial. Br Med J 1973;4:695–701.
   PubMed Web of Science ®Google Scholar
• Bouillon R, Reynaert J, Claes JH, The effect of anticonvulsant therapy on serum levels of 25-hydroxy-vitamin D, calcium, and parathyroid hormone. J Clin Endocrinol Metab 1975;41:1130–5.
   PubMed Web of Science ®Google Scholar
• Sumi K, Sugita T, Shimotsuji T, Effect of anticonvulsant therapy on serum 25-hydroxyvitamin D level. Tohoku J Exp Med 1978;125:265–9.
   PubMedGoogle Scholar
• Kulak CA, Borba VZ, Silvado CE, Bone density and bone turnover markers in patients with epilepsy on chronic antiepileptic drug therapy. Arq Bras Endocrinol Metabol 2007;51:466–71.
   PubMedGoogle Scholar
• Pack AM, Morrell MJ, Randall A, Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy. Neurology 2008;70:1586–93.
   PubMed Web of Science ®Google Scholar
• Rieger-Wettengl G, Tutlewski B, Stabrey A, Analysis of the musculoskeletal system in children and adolescents receiving anticonvulsant monotherapy with valproic acid or carbamazepine. Pediatrics 2001;108:E107.
   PubMed Web of Science ®Google Scholar
• Andress DL, Ozuna J, Tirschwell D, Antiepileptic drug-induced bone loss in young male patients who have seizures. Arch Neurol 2002;59:781–6.
   PubMed Web of Science ®Google Scholar
• Tsukahara H, Kimura K, Todoroki Y, Bone mineral status in ambulatory pediatric patients on long-term anti-epileptic drug therapy. Pediatr Int 2002;44:247–53.
   PubMed Web of Science ®Google Scholar
• Babayigit A, Dirik E, Bober E, Cakmakci H. Adverse effects of antiepileptic drugs on bone mineral density. Pediatr Neurol 2006;35:177–81.
   PubMed Web of Science ®Google Scholar
• Verrotti A, Agostinelli S, Coppola G, A 12-month longitudinal study of calcium metabolism and bone turnover during valproate monotherapy. Eur J Neurol 2010;17:232–7.
   PubMed Web of Science ®Google Scholar
• Nettekoven S, Ströhle A, Trunz B, Effects of antiepileptic drug therapy on vitamin D status and biochemical markers of bone turnover in children with epilepsy. Eur J Pediatr 2008;167:1369–77.
   PubMed Web of Science ®Google Scholar
• Ali II, Herial NA, Orris M, Migraine prophylaxis with topiramate and bone health in women. Headache 2011;51:613–6.
   PubMedGoogle Scholar
• Heo K, Rhee Y, Lee HW, The effect of topiramate monotherapy on bone mineral density and markers of bone and mineral metabolism in premenopausal women with epilepsy. Epilepsia 2011;52:1884–9.
   PubMed Web of Science ®Google Scholar
• Ali II, Herial NA, Horrigan T, Measurement of bone mineral density in patients on levetiracetam monotherapy. Am Epilepsy Soc Abstr 2006;2:150.
   Google Scholar
• Koo DL, Joo EY, Kim D, Hong SB. Effects of levetiracetam as a monotherapy on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy. Epilepsy Res 2012;104:134–9.
   PubMedGoogle Scholar
• Babacan O, Karaoglu A, Vurucu S, May long term oxcarbazepine treatment be lead to secondary hyperparathyroidism? J Clin Neurol 2012;8:65–8.
   PubMedGoogle Scholar
• Cansu A, Yesilkaya E, Serdaroğlu A, Evaluation of bone turnover in epileptic children using oxcarbazepine. Pediatr Neurol 2008;39:266–71.
   PubMed Web of Science ®Google Scholar
• Verrotti A, Matricardi S, Manco R, Chiarelli F. Bone metabolism and vitamin D levels in carbamazepine-treated patients. Epilepsia 2006;47:1586.
   PubMedGoogle Scholar
• Lambrinoudaki I, Kaparos G, Armeni E, BsmI vitamin D receptor's polymorphism and bone mineral density in men and premenopausal women on long-term antiepileptic therapy. Eur J Neurol 2011;18:93–8.
   PubMed Web of Science ®Google Scholar
• Brodie MJ, Mintzer S, Pack AM, Enzyme induction with antiepileptic drugs: Cause for concern? Epilepsia 2013;54:11–27.
   PubMed Web of Science ®Google Scholar
• Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with use of antiepileptic drugs. Epilepsia 2004;45:1330–7.
   PubMed Web of Science ®Google Scholar
• Mikati MA, Dib L, Yamout B, Two randomized vitamin D trials in ambulatory patients on anticonvulsants: impact on bone. Neurology 2006;67:2005–14.
   PubMed Web of Science ®Google Scholar
• Mintzer S. Metabolic consequences of antiepileptic drugs. Curr Opin Neurol 2010;23:164–9.
   PubMed Web of Science ®Google Scholar
• Pack AM. Treatment of epilepsy to optimize bone health. Curr Treat Options Neurol 2011;13:346–54.
   PubMed Web of Science ®Google Scholar
• Hamed SA. Influences of bone and mineral metabolism in epilepsy. Expert Opin Drug Saf 2011;10:265–80.
   PubMed Web of Science ®Google Scholar
• Wallace H, Shorvon S, Tallis R. Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy. Lancet 1998;352:1970–3.
   PubMed Web of Science ®Google Scholar
• Sukumaran SC, Sarma PS, Thomas SV. Polytherapy increases the risk of infertility in women with epilepsy. Neurology 2010;75:1351–5.
   PubMedGoogle Scholar
• Verrotti A, D'Egidio C, Mohn A, Antiepileptic drugs, sex hormones, and PCOS. Epilepsia 2011;52:199–211.
   PubMed Web of Science ®Google Scholar
• Bauer J, Isojärvi JI, Herzog AG, Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management. J Neurol Neurosurg Psychiatry 2002;73:121–5.
   PubMed Web of Science ®Google Scholar
• Thomson RL, Spedding S, Buckley JD. Vitamin D in the aetiology and management of polycystic ovary syndrome. Clin Endocrinol (Oxf) 2012;77:343–50.
   PubMed Web of Science ®Google Scholar
• Lerchbaum E, Obermayer-Pietsch B. Vitamin D and fertility: a systematic review. Eur J Endocrinol 2012;166:765–78.
   PubMed Web of Science ®Google Scholar
• Malow BA. Searching for autism symptomatology in children with epilepsy–a new approach to an established comorbidity. Epilepsy Curr 2006;6:150–2.
   PubMedGoogle Scholar
• Viscidi EW, Triche EW, Pescosolido MF, Clinical characteristics of children with autism spectrum disorder and co-occurring epilepsy. PLoS One 2013 4(8):e67797.
   Google Scholar
• Lo-Castro A, Curatolo P. Epilepsy associated with autism and attention deficit hyperactivity disorder: Is there a genetic link? Brain Dev 2013 doi:pii: S0387-7604(13)00162-9. 10.1016/j.braindev.2013.04.013
   PubMedGoogle Scholar
• Grant WB, Soles CM. Epidemiologic evidence for supporting the role of maternal vitamin D deficiency as a risk factor for the development of infantile autism. Dermatoendocrinol 2009;1:223–8. Erratum, 2009:1:315.
   PubMedGoogle Scholar
• Clarke DF, Roberts W, Daraksan M, The prevalence of autistic spectrum disorder in children surveyed in a tertiary care epilepsy clinic. Epilepsia 2005;46:1970–7.
   PubMedGoogle Scholar
• Matsuo M, Maeda T, Sasaki K, Frequent association of autism spectrum disorder in patients with childhood onset epilepsy. Brain Dev 2010;32:759–63.
   PubMedGoogle Scholar
• Bromley RL, Mawer G, Clayton-Smith J, Autism spectrum disorders following in utero exposure to antiepileptic drugs. Neurology 2008;2(71):1923–4.
   Google Scholar
• Evatt ML, DeLong MR, Grant WB, Autism spectrum disorders following in utero exposure to antiepileptic drugs. Neurology 2009;73:997.
   PubMedGoogle Scholar
• Holick MF, Binkley NC, Bischoff-Ferrari HA, Endocrine society. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911–30.
   PubMed Web of Science ®Google Scholar
• Wirrell E. Vitamin D and bone health in children with epilepsy: fad or fact? Pediatr Neurol 2010;42:394–5.
   PubMedGoogle Scholar
• Shellhaas RA, Joshi SM. Vitamin D and bone health among children with epilepsy. Pediatr Neurol 2010;42:385–93.
   PubMed Web of Science ®Google Scholar
• Valsamis HA, Arora SK, Labban B, McFarlane SI. Antiepileptic drugs and bone metabolism. Nutr Metab (Lond) 2006;3:36.
   PubMedGoogle Scholar